The use of epidural analgesia (EA) has been suggested as an integral part of an enhanced recovery program for colorectal surgery. However, the effects of EA on postoperative outcomes and hospital length of stay remain controversial. Data from the American College of Surgeons National Surgical Quality Improvement Program database for 2014 and 2015 were queried for adult patients who underwent elective open colorectal surgery. We included only cases with general anesthesia as the main anesthetic. Cases with other types of anesthesia were excluded. A 1:3 matched sample of EA versus non-EA cases was created based on propensity scores. The primary outcome of interest was the occurrence of major cardiopulmonary complications within 7 days of the surgery. Secondary outcome measures were hospital length of stay and 30-day mortality. A total of 24,927 patients were included in the analysis. EA was utilized in 15.02% (n = 3745). The cumulative risk over the study period for major cardiopulmonary complications was 2.52% (n = 627). There were no statistically significant differences in the rate of postoperative complications (relative risk 0.91, 95% CI 0.66-1.27, P = 0.59), length of stay (median [interquartile range], EA 6 [5] [6] [7] [8] [9] versus non-EA 6 [4] [5] [6] [7] [8] [9] days, P = 0.36), and 30-day mortality rate (relative risk 0.71, 95% CI 0.42-1.20, P = 0.20) between the two propensity-matched cohorts. In conclusion, our study revealed that the benefits of EA in patients undergoing open colorectal surgery are limited, as it does not influence immediate postoperative cardiopulmonary complications or hospital length of stay.
A dequate dynamic pain control is a critical component of an enhanced recovery after surgery (ERAS) pathway (1-3). Epidural analgesia (EA) has been suggested as an integral part of an ERAS protocol for open colorectal surgery because it provides excellent dynamic pain relief (2, 4) . However, several studies have revealed confl icting results with regard to the benefi ts of EA (5) (6) (7) (8) . A systematic review of randomized controlled trials (RCTs) concluded that in the setting of an ERAS program, EA does not improve recovery or reduce postoperative morbidity after open abdominal surgery (7) . In contrast, another systematic review found that EA reduced the hospital length of stay (LOS), but the quality of evidence was low (8) . Th e concerns with these systematic reviews are that the RCTs included in these analyses are older, which may not represent current rapidly changing perioperative care for open abdominal colorectal surgery (5) . Th erefore, we evaluated the eff ects of EA on the incidence of major postoperative cardiopulmonary complications, hospital LOS, and 30-day mortality after open colorectal surgery using the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP) database. We hypothesized that use of EA is associated with a reduced rate of postoperative cardiopulmonary complications (the primary outcome measure).
METHODS
Data for 2014 and 2015 were obtained from the ACS-NSQIP database, which provides multicenter, outcome-oriented data that are prospectively and rigorously collected by dedicated personnel (9) . Th ese data are collected from participating US and international hospitals (with 603 participating sites up to 2015). At each hospital, a surgical clinical reviewer, using a standardized and strict protocol, extracts information for welldefi ned variables, including preoperative comorbidities and laboratory data, patients' demographics, procedure-related and intraoperative information, and 30-day postoperative morbidity and mortality. Th e ACS-NSQIP auditing and systematic sampling processes are designed to ensure the collection of highquality data with minimized bias. Details regarding the ASC-NSQIP sampling, auditing, inclusion, and exclusion processes have been published (10) . Th e ACS-NSQIP consists of publicly available, deidentifi ed data, and thus the study was considered to be exempt from review by the University of Texas Southwestern Medical Center, Dallas, Texas, Institutional Review Board.
Adult patients (18 years or older) who underwent elective open colorectal surgery identifi ed using current procedural terminology codes were included in the analyses. Laparoscopic, robotic-assisted, outpatient, and emergent cases were excluded, as were any cases that involved preoperative sepsis, disseminated cancer, or the need for ventilator support. We included only cases with general anesthesia as the main anesthetic.
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Ahmad Elsharydah, MD, MBA, Leila W. Zuo, MD, Abu Minhajuddin, PhD, and Girish P. Joshi, MBBS, MD Th e primary outcome of interest was the occurrence of the composite of major cardiopulmonary complications (MCPCs), including acute myocardial infarction, cardiac arrest, pneumonia, ventilatory support for >48 hours, and unplanned intubation within 7 days after the surgery. Th ese major complications were combined in one binary variable (1, 0) . Th e secondary outcome measures investigated were the hospital LOS and 30-day mortality.
Patients who received EA were matched in a 1:3 matching with a similar group of patients who did not receive EA based on calculated propensity scores. Because we excluded all patients who received other regional analgesic techniques such as transversus abdominis plane blocks, we assumed that the nonepidural groups received traditional postoperative analgesia (i.e., primarily pharmacological treatments). A multiple logistic regression model was utilized to calculate the propensity scores after controlling for the patient's demographic characteristics (i.e., age, race, and gender), preoperative comorbidities (utilizing modifi ed Charlson comorbidity index) (11, 12) , smoking status, and complexity of procedure (utilizing the work value unit of the procedure as an indication of the complexity of the surgery). Modifi ed Charlson comorbidity index scores are calculated as follows: a score of 1 is assigned for a history of chronic obstructive pulmonary disease, chronic heart failure, myocardial infarction, peripheral vascular disease/rest pain, diabetes, or cerebrovascular disease (transient ischemic attack or stroke). A score of 2 is assigned for patients on dialysis, patients with radiation and chemotherapy without disseminated cancer, or patients with hemiplegia. Patients with ascites or esophageal varices receive a score of 3, and patients with disseminated cancer, a score of 6. Also, one point is added for each decade beyond 40 years of age.
Descriptive statistics of the unmatched sample were obtained utilizing univariate analyses of PROC FREQ of the SAS software; SAS 9.4 software (Cary, NC) was used for all statistical analyses. Discrete variables are presented as frequencies and percentages. Continuous variables are summarized as means and standard errors or medians and interquartile ranges. Student's t test was used to compare the continuous variables between the EA and the non-EA groups in the unmatched sample. To examine the association with diff erent categorical variables in the unmatched sample, the chi-square statistical method was used. A 1:3 case-control propensity score-matched sampling of the EA and the non-EA groups was done using a greedy 8 to 1 digit-matching algorithm technique without replacement (13) . Th e two matched cohorts (EA and non-EA) were compared utilizing conditional logistic regression analyses and McNemar's tests (for dichotomous variables). Additionally, generalized linear mixed models (Glimmix procedure of the SAS software) were used to assess the association of EA with LOS in the matched sample. All statistical analyses were two-tailed, and a P value of 0.05 was considered statistically signifi cant.
RESULTS
Of the 24,927 patients who met the inclusion criteria, EA was provided for 15.02% (n = 3745). Within 7 days of the surgery, at least one MCPC was encountered in 627 patients, which corresponds to a 2.52% cumulative risk over the 2-year study period. Some patients had more than one MCPC. Th e cumulative risk for 30-day mortality was 1.24% (n = 309) over the study period. Th ere were no statistically signifi cant diff erences between the EA and the non-EA groups in the MCPC rates and 30-day mortality in the unmatched sample (Table) .
Th e 1:3 propensity-matched samples had 2107 patients in the EA group and 6321 patients in the non-EA group. Because of missing data during the matching process, 1638 EA cases were excluded. Good matching was achieved between the EA and non-EA groups, as refl ected by P > 0.39 for the explanatory variables in the matched sample (Table) . DISCUSSION Th e main fi ndings of this study are that EA did not infl uence the MCPC rate, hospital LOS, and 30-day mortality after open colorectal surgery. Th e strength of this study includes use of current data (i.e., 2014 and 2015); therefore, the information refl ects modern perioperative practice. Furthermore, the sample size in this study was large compared with previous studies. Also, we used propensity matching, which allows better control for confounders and bias and provides an ability to elucidate the diff erences. In addition, we were able to match the EA and non-EA groups at a 1:3 ratio for socioeconomic, medical, and surgical factors without signifi cant reduction in the sample size.
Our fi ndings contradict the recommendations from the ERAS Society (www.erassociety.org) that emphasize the use of EA for open colorectal surgical procedures (2) . Interestingly, previous analysis of the data, collected between 2008 and 2013, from an international, multicenter ERAS registry maintained by the ERAS Society found that use of EA was associated with longer hospital LOS (14) . In contrast to our fi ndings, a Cochrane systematic review of RCTs in patients undergoing abdominal surgery found that EA was associated with reduced hospital LOS after open abdominal surgery (8) . However, the RCTs included in these metaanalyses were performed before the introduction of ERAS programs.
Th e use of EA in our study population in 2014 and 2015 was about 15%, which is higher than that reported previously by Halabi et al (6) , who observed an EA rate of 4.4% between 2002 and 2010. Th e higher EA rate observed in our study may be related to recommendations by the ERAS Society. Another possible reason for the low rate reported previously could be undercoding of EA in the administrative data utilized (i.e., the Nationwide Inpatient Sample) (15) . In contrast, the EA rate reported by Cummings et al (16) in patients undergoing colorectal cancer surgery between 1996 and 2005 was 22.9%, slightly higher than that observed in our study. Th e higher rate is most likely because the patient population included in the Cummings study was older (>66 years) and may have had several comorbid conditions. On the other hand, our EA rate may be underestimated because of the strict exclusion criteria for our study. For example, our study excluded all cases with EA combined with other types of analgesic techniques.
In recent years, there have been several reports of association between EA and survival after cancer surgery, possibly due to reduced perioperative complications (17) . A large (n = 42,151) propensity-matched retrospective cohort study in patients with nonmetastatic cancer undergoing colorectal surgery found that EA was associated with improved survival (16) . In contrast, secondary analysis of data from large multicenter RCTs assessing eff ects of EA on outcomes after major surgery found no diff erence in mortality in the subset of patients undergoing surgery for abdominal malignancies (18) . A recent analysis of the claims database of a large nationwide commercial health insurer found that EA did not infl uence persistent opioid use (19) . Overall, it is unclear if EA or several other confounding factors such as type of cancer, blood transfusion, need for postoperative chemotherapy and radiation therapy, and reduced opioid use were the reasons for improved outcome after cancer surgery.
Based on our fi ndings, it appears that the role of EA in the modern perioperative care of patients undergoing open colorectal surgery is limited. One of the major limitations of EA is that it may delay ambulation, which is a major contributor to enhanced recovery. Th e reasons for delayed ambulation associated with EA include the presence of catheter and pumps, the presence of muscular weakness, and postural hypotension. Given these limitations of EA, there is an increased interest in alternate methods of analgesia, including fi eld blocks such as transversus abdominis block (20) and surgical site local anesthetic infi ltration with or without continuous local anesthetic infusion in the surgical wound (3, 21) . Th ese methods have been shown to be eff ective analgesics when combined with nonopioid analgesics such as acetaminophen and nonsteroidal anti-infl ammatory drugs as well as analgesic adjuncts such as steroids (e.g., dexamethasone) (3).
Th is study has several limitations, particularly those related to its retrospective nature. In addition, the limitations are related to use of databases, including the possibility that EA may be under-or overcoded. In addition, the database has limited information about details of the other nonopioid analgesic techniques used and postoperative outcomes. Furthermore, it is not possible to determine from the database which patients were part of an ERAS program. However, we assessed the practices in the past 2 years because perioperative care is rapidly changing and implementation of ERAS programs is increasingly becoming popular. Furthermore, the data were collected only from ACS-NSQIP participating hospitals (many of which are academic institutions), which may lead to sampling bias. Details of the ACS-NSQIP database limitations are described in its Participant Use Data File user guide (10) . We assessed the composite of MCPC because of a smaller number of patients with individual cardiac and pulmonary complications, which may not provide clinically useful information. Also, we assessed the complications in the immediate postoperative period (i.e., within 7 days of surgery) because EA is typically used for 3 days after surgery and any directly related complication would be recognized within 7 days. Finally, the fi ndings of this study can only interpret associations and do not prove causation.
In summary, this study revealed that there was no association between EA and improved postoperative complications and hospital LOS. Our data provide support for the notion that EA should not be considered the "gold standard" for pain management after open colorectal surgery. Future studies are necessary to compare the outcomes with EA compared with other multimodal analgesia modalities when implemented in an ERAS protocol for open colorectal surgery.
